; (B) screening adolescents and women for interpersonal and domestic violence at least annually, and, when needed, providing or referring for initial intervention services, including counseling, education, harm reduction strategies, and other appropriate supportive services; (C) screening for gestational diabetes mellitus; (D) screening for cervical cancer, and where recommended, co-testing with cytology and human papillomavirus testing; (E) directed behavioral counseling for sexually transmitted infections; (F) prevention education, risk assessment, and screening for human immunodeficiency virus infection, including screening for pregnant women; (G) contraceptive care, including— (i) the full range of female-controlled contraceptive methods approved by the Food and Drug Administration, effective family planning practices, and sterilization procedures to prevent unintended pregnancy and improve birth outcomes; (ii) contraceptive counseling, initiation of contraceptive use, and follow-up care (such as management and evaluation, and changes to, and removal or discontinuation of, the contraceptive method); and (iii) instruction in fertility awareness-based methods, including the lactation amenorrhea method, for women desiring an alternative method; (H) screening for breast cancer; (I) at least one well-woman preventive care visit per year for adolescent and adult women in order to deliver and coordinate recommended preventive services, including preconception and many services necessary for prenatal and interconception care, in accordance with recommendations based on age and risk factors; and (J) any other baseline requirements prescribed by the Health Resources and Service Administration for women; and